Nataliya Papulova
Research Subjects
Nataliya Papulova has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Bayan Aigozhina
Department of Otorhinolaryngology, Astana Medical University, Astana 010000, Kazakhstan
2 shared publications - D. S. Kasenova
Astana Medical University
2 shared publications - A. Mustafin
Astana Medical University, Beybitshilik str., 49A, Astana, 010000
1 shared publication - Aliya Turayeva
Department of Otorhinolaryngology, NCJSC "Astana Medical University", Astana, Kazakhstan
1 shared publication - Almat Bekpan
Ph.D., Corporate Fund “University Medical Center”, Astana, Kazakhstan
1 shared publication - G. Mukhamadieva
Astana Medical University, Beybitshilik str., 49A, Astana, 010000
1 shared publication
Latest Publications
- 22 September 2026
- Published by Elsevier in Journal of Voice
Epidemiological and Surgical Outcomes of 321 Pediatric Subglottic Stenoses: A Retrospective Study
- 22 September 2026
- Published by Elsevier in Journal of Voice
Epidemiological and Surgical Outcomes of 321 Pediatric Subglottic Stenoses: A Retrospective Study
- 30 August 2026
- Published by Semey Medical University in Наука и здравоохранение
- No. 4(28),p. 263-273
THE ROLE OF VITAMIN «D» IN THE TREATMENT OF CHRONIC RHINOSINUSITIS WITH NASAL POLYPS. LITERATURE REVIEW
Relevance. Chronic rhinosinusitis with nasal polyps (CRSwNP) is a severe inflammatory endotype of chronic rhinosinusitis characterised by persistent Type 2 immune activation, epithelial barrier dysfunction, tissue remodelling, and a high rate of postoperative recurrence despite advances in functional endoscopic sinus surgery (FESS) and biologic therapy. Vitamin D (25-hydroxyvitamin D, 25(OH)D) has emerged as an important immunomodulatory factor involved in sinonasal mucosal homeostasis. Aim. Analysis of current clinical, molecular, and translational data on the role of vitamin D in the pathogenesis of CRSwNP, its therapeutic potential, and its relevance for relapse prevention according to the literature. Search strategy. ublications indexed in PubMed, Scopus, Web of Science, the Cochrane Library, and eLibrary (RSCI) between 2015 and 2025 were reviewed. Fifteen key studies investigating serum 25(OH)D levels, vitamin D receptor (VDR) polymorphisms, and clinically relevant outcomes in CRSwNP were included. Results. Evidence indicates that vitamin D supports mucosal homeostasis by enhancing epithelial barrier integrity through upregulation of tight junction proteins (ZO-1, occludin), inducing antimicrobial peptides such as cathelicidin (LL-37), suppressing Type 2 inflammation, and modulating tissue remodelling pathways. Clinically, vitamin D deficiency (serum 25(OH)D <20 ng/mL) is associated with higher Lund–Mackay CT scores and an increased risk of postoperative polyp recurrence following FESS. In addition, vitamin D may enhance corticosteroid responsiveness and potentially improve the effectiveness of biologic therapy through better control of inflammatory activity. Conclusion. Vitamin D status appears to be an independent predictor of disease severity and recurrence in CRSwNP. Maintaining serum 25(OH)D levels above 30 ng/mL may contribute to epithelial barrier preservation, attenuation of Type 2 inflammation, and reduction of disease recurrence. Routine assessment of vitamin D status and targeted supplementation should be considered within perioperative management strategies for CRSwNP. Актуальность. Хронический риносинусит с полипами носа (CRSwNP) является тяжелым воспалительным эндотипом хронического риносинусита, характеризующимся стойкой иммунной активацией 2-го типа, нарушением функции эпителиального барьера, ремоделированием тканей и высокой частотой послеоперационных рецидивов, несмотря на достижения функциональной эндоскопической хирургии околоносовых пазух (FESS) и биологической терапии. Витамин D рассматривается как важный иммуномодулирующий фактор, участвующий в регуляции воспалительных процессов в слизистой оболочке полости носа и околоносовых пазух. Цель. Анализ современных клинических, молекулярных и трансляционных данных о роли витамина D в патогенезе CRSwNP, его терапевтическом потенциале и его значимости для профилактики рецидивов по данным литературы. Стратегия поиска. Проведен поиск публикаций в базах PubMed, Scopus, Web of Science, Cochrane Library и eLibrary (РИНЦ) за период 2015–2025 гг. Проанализированы 15 ключевых исследований, посвященных уровню сывороточного 25(OH)D, полиморфизмам рецептора витамина D (VDR) и клиническим исходам при CRSwNP. Результаты. Установлено, что витамин D способствует поддержанию гомеостаза слизистой оболочки за счет усиления экспрессии белков плотных контактов (ZO-1, окклюдин), индукции антимикробного пептида кателицидина (LL-37), подавления воспаления 2-го типа и регуляции процессов ремоделирования тканей. Дефицит витамина D (25(OH)D <20 нг/мл) ассоциирован с более высокими показателями по шкале Lund–Mackay и увеличением риска послеоперационного рецидива полипов после FESS до 3,5 раза. Кроме того, витамин D способен повышать чувствительность к кортикостероидам и потенциально усиливать эффективность биологической терапии. Заключение. Статус витамина D может рассматриваться как независимый предиктор тяжести заболевания и риска рецидива при CRSwNP. Поддержание уровня 25(OH)D выше 30 нг/мл может способствовать сохранению целостности эпителиального барьера, снижению выраженности воспаления 2-го типа и уменьшению частоты рецидивов. Целесообразно включение оценки уровня 25(OH)D и его коррекции в комплексное ведение пациентов с CRSwNP. Өзектілігі. Мұрын полиптері бар...
- 30 August 2026
- Published by Semey Medical University in Наука и здравоохранение
- No. 4(28),p. 263-273
THE ROLE OF VITAMIN «D» IN THE TREATMENT OF CHRONIC RHINOSINUSITIS WITH NASAL POLYPS. LITERATURE REVIEW
Relevance. Chronic rhinosinusitis with nasal polyps (CRSwNP) is a severe inflammatory endotype of chronic rhinosinusitis characterised by persistent Type 2 immune activation, epithelial barrier dysfunction, tissue remodelling, and a high rate of postoperative recurrence despite advances in functional endoscopic sinus surgery (FESS) and biologic therapy. Vitamin D (25-hydroxyvitamin D, 25(OH)D) has emerged as an important immunomodulatory factor involved in sinonasal mucosal homeostasis. Aim. Analysis of current clinical, molecular, and translational data on the role of vitamin D in the pathogenesis of CRSwNP, its therapeutic potential, and its relevance for relapse prevention according to the literature. Search strategy. ublications indexed in PubMed, Scopus, Web of Science, the Cochrane Library, and eLibrary (RSCI) between 2015 and 2025 were reviewed. Fifteen key studies investigating serum 25(OH)D levels, vitamin D receptor (VDR) polymorphisms, and clinically relevant outcomes in CRSwNP were included. Results. Evidence indicates that vitamin D supports mucosal homeostasis by enhancing epithelial barrier integrity through upregulation of tight junction proteins (ZO-1, occludin), inducing antimicrobial peptides such as cathelicidin (LL-37), suppressing Type 2 inflammation, and modulating tissue remodelling pathways. Clinically, vitamin D deficiency (serum 25(OH)D <20 ng/mL) is associated with higher Lund–Mackay CT scores and an increased risk of postoperative polyp recurrence following FESS. In addition, vitamin D may enhance corticosteroid responsiveness and potentially improve the effectiveness of biologic therapy through better control of inflammatory activity. Conclusion. Vitamin D status appears to be an independent predictor of disease severity and recurrence in CRSwNP. Maintaining serum 25(OH)D levels above 30 ng/mL may contribute to epithelial barrier preservation, attenuation of Type 2 inflammation, and reduction of disease recurrence. Routine assessment of vitamin D status and targeted supplementation should be considered within perioperative management strategies for CRSwNP. Актуальность. Хронический риносинусит с полипами носа (CRSwNP) является тяжелым воспалительным эндотипом хронического риносинусита, характеризующимся стойкой иммунной активацией 2-го типа, нарушением функции эпителиального барьера, ремоделированием тканей и высокой частотой послеоперационных рецидивов, несмотря на достижения функциональной эндоскопической хирургии околоносовых пазух (FESS) и биологической терапии. Витамин D рассматривается как важный иммуномодулирующий фактор, участвующий в регуляции воспалительных процессов в слизистой оболочке полости носа и околоносовых пазух. Цель. Анализ современных клинических, молекулярных и трансляционных данных о роли витамина D в патогенезе CRSwNP, его терапевтическом потенциале и его значимости для профилактики рецидивов по данным литературы. Стратегия поиска. Проведен поиск публикаций в базах PubMed, Scopus, Web of Science, Cochrane Library и eLibrary (РИНЦ) за период 2015–2025 гг. Проанализированы 15 ключевых исследований, посвященных уровню сывороточного 25(OH)D, полиморфизмам рецептора витамина D (VDR) и клиническим исходам при CRSwNP. Результаты. Установлено, что витамин D способствует поддержанию гомеостаза слизистой оболочки за счет усиления экспрессии белков плотных контактов (ZO-1, окклюдин), индукции антимикробного пептида кателицидина (LL-37), подавления воспаления 2-го типа и регуляции процессов ремоделирования тканей. Дефицит витамина D (25(OH)D <20 нг/мл) ассоциирован с более высокими показателями по шкале Lund–Mackay и увеличением риска послеоперационного рецидива полипов после FESS до 3,5 раза. Кроме того, витамин D способен повышать чувствительность к кортикостероидам и потенциально усиливать эффективность биологической терапии. Заключение. Статус витамина D может рассматриваться как независимый предиктор тяжести заболевания и риска рецидива при CRSwNP. Поддержание уровня 25(OH)D выше 30 нг/мл может способствовать сохранению целостности эпителиального барьера, снижению выраженности воспаления 2-го типа и уменьшению частоты рецидивов. Целесообразно включение оценки уровня 25(OH)D и его коррекции в комплексное ведение пациентов с CRSwNP. Өзектілігі. Мұрын полиптері бар...
- Open Access
- 28 December 2024
- Published by Dnipro State Medical University in Medicni perspektivi
- Vol. 29 (4) , 4-13
Ear and skull base paraganglioma: review of literature
The actuality of the research is determined by the lack of systemized information on the ear and skull base paraganglioma. Currently, from 500 to 1000 cases of paraganglioma or pheochromocyte are diagnosed in the United States of America annually. The combined morbidity of benign tumor forms is evaluated to be between 0.7 to 1.0 for 100000 people per year. Even though the results in understanding the nature of paraganglioma, as well as treatment thereof, are successful, the amount of literature on this topic only increases. The research aims to analyze study of the terminology, classification, diagnostics, and treatment of paraganglioma. Special attention was brought to the preoperative preparation and embolization of vessels, which supply blood to the tumor as well as to the problem of repeated bouts of glomangioma. The objective of the research is the selection of relative sources, argumentation analysis, and material systematization. For the analysis, 53 research articles were included. During the compilation of this study, such methods, as analysis, synthesis, information collection and systematization, and generalization, were used. In this article, various paraganglioma classifications, endoscopic treatment methods, other aspects of paraganglioma therapy, and diagnosis and treatment thereof, were presented. More and more researchers recommend individual and adapted approaches for each case with the inclusion of factors, related to the patient, including age, treatment goals, other infections, gene status, anatomical issues, caused by the tumor growth, its sizes, and other factors. This literature review focuses on ear and skull base paragangliomas, rare, usually benign, hyper-vascularized neuroendocrine tumors often treated surgically. Alternative treatments like cyber-knife, gamma-knife, and endoscopic approaches are also discussed, highlighting their efficacy for specific cases. The study emphasizes individualized treatment plans considering patient-specific factors, with stereotactic radiosurgery being a safe and effective option for many patients. Materials of the research can be used by doctors of various specializations to enrich their knowledge and for further study of paragangliomas of various localizations.
- 28 December 2024
- Published by Dnipro State Medical University in Medicni perspektivi
- Vol. 29 (4) , 4-13
Open AccessEar and skull base paraganglioma: review of literature
The actuality of the research is determined by the lack of systemized information on the ear and skull base paraganglioma. Currently, from 500 to 1000 cases of paraganglioma or pheochromocyte are diagnosed in the United States of America annually. The combined morbidity of benign tumor forms is evaluated to be between 0.7 to 1.0 for 100000 people per year. Even though the results in understanding the nature of paraganglioma, as well as treatment thereof, are successful, the amount of literature on this topic only increases. The research aims to analyze study of the terminology, classification, diagnostics, and treatment of paraganglioma. Special attention was brought to the preoperative preparation and embolization of vessels, which supply blood to the tumor as well as to the problem of repeated bouts of glomangioma. The objective of the research is the selection of relative sources, argumentation analysis, and material systematization. For the analysis, 53 research articles were included. During the compilation of this study, such methods, as analysis, synthesis, information collection and systematization, and generalization, were used. In this article, various paraganglioma classifications, endoscopic treatment methods, other aspects of paraganglioma therapy, and diagnosis and treatment thereof, were presented. More and more researchers recommend individual and adapted approaches for each case with the inclusion of factors, related to the patient, including age, treatment goals, other infections, gene status, anatomical issues, caused by the tumor growth, its sizes, and other factors. This literature review focuses on ear and skull base paragangliomas, rare, usually benign, hyper-vascularized neuroendocrine tumors often treated surgically. Alternative treatments like cyber-knife, gamma-knife, and endoscopic approaches are also discussed, highlighting their efficacy for specific cases. The study emphasizes individualized treatment plans considering patient-specific factors, with stereotactic radiosurgery being a safe and effective option for many patients. Materials of the research can be used by doctors of various specializations to enrich their knowledge and for further study of paragangliomas of various localizations.
- 2 June 2024
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 102 (3) , 247-251
Comparative characteristics of the nasal airflow aerodynamic parameters in patients with nasal septum deformation and healthy participants
Surgical treatment of nasal septum deviation or deformity (NSD) is a common method of treatment. The quality of treatment is assessed visually with rhinoscopy, taking into account subjective patient sensations. However, there are still no objective criteria for assessing nasal airflow improvement, which complicates the evaluation of patient breathing after treatment. We used a novel CFD modeling method to create a virtual airflow model and determine flow parameters in the nasal cavity in normal and pathological conditions.Objective: to compare the aerodynamic characteristics of airflow in patients with NSD and healthy nasal cavities.Material and methods: the study used electronic files of computed tomography scans of the nasal sinuses of 60 patients with NSD and 21 healthy participants. Specific software (3D slicer, Ansys Fluent) was used to obtain airflow parameters; 3D models of the nasal cavity airflow were created, and CFD flow modeling was conducted.Results: in patients with NSD, flow velocity ranged from 5.17 to 15.63 m/s, in healthy individuals from 1.1 to 2.0 m/s; pressure force on the nasal walls ranged from 2.20 to 10.20 Pa in patients with NSD, in healthy individuals from 0.60 to 1.00 Pa; flow temperature ranged from 26.45 to 36.80 °C in patients with NSD, in healthy individuals from 20.14 to 24.40 °C; flow partial pressure ranged from –120.60 to –0.01 Pa in patients with NSD, in healthy individuals from 2.00 to –4.80 Pa, p < 0.0001. Conclusion: Aerodynamic characteristics of nasal cavity airflow in patients with nasal septum deviation significantly differ from those in healthy individuals. The application of CFD modeling of nasal airflow will assist clinicians in objectively assessing nasal breathing in NSD, as well as surgical treatment outcomes and quality assessment in otorhinolaryngological practice.
- 2 June 2024
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 102 (3) , 247-251
Comparative characteristics of the nasal airflow aerodynamic parameters in patients with nasal septum deformation and healthy participants
Surgical treatment of nasal septum deviation or deformity (NSD) is a common method of treatment. The quality of treatment is assessed visually with rhinoscopy, taking into account subjective patient sensations. However, there are still no objective criteria for assessing nasal airflow improvement, which complicates the evaluation of patient breathing after treatment. We used a novel CFD modeling method to create a virtual airflow model and determine flow parameters in the nasal cavity in normal and pathological conditions.Objective: to compare the aerodynamic characteristics of airflow in patients with NSD and healthy nasal cavities.Material and methods: the study used electronic files of computed tomography scans of the nasal sinuses of 60 patients with NSD and 21 healthy participants. Specific software (3D slicer, Ansys Fluent) was used to obtain airflow parameters; 3D models of the nasal cavity airflow were created, and CFD flow modeling was conducted.Results: in patients with NSD, flow velocity ranged from 5.17 to 15.63 m/s, in healthy individuals from 1.1 to 2.0 m/s; pressure force on the nasal walls ranged from 2.20 to 10.20 Pa in patients with NSD, in healthy individuals from 0.60 to 1.00 Pa; flow temperature ranged from 26.45 to 36.80 °C in patients with NSD, in healthy individuals from 20.14 to 24.40 °C; flow partial pressure ranged from –120.60 to –0.01 Pa in patients with NSD, in healthy individuals from 2.00 to –4.80 Pa, p < 0.0001. Conclusion: Aerodynamic characteristics of nasal cavity airflow in patients with nasal septum deviation significantly differ from those in healthy individuals. The application of CFD modeling of nasal airflow will assist clinicians in objectively assessing nasal breathing in NSD, as well as surgical treatment outcomes and quality assessment in otorhinolaryngological practice.